Description
Biomolecule IGF-1 LR3 is a research-grade product containing Long R3 Insulin-like Growth Factor 1 (IGF-1 LR3), a modified analogue of human IGF-1. It has been developed for laboratory research involving growth-factor signalling, cellular metabolism, and mechanisms related to cell growth and differentiation.
IGF-1 LR3 is structurally modified to reduce its binding to IGF-binding proteins compared with native IGF-1. This modification can affect its interaction with the IGF system and makes it a subject of research into IGF-related biological pathways.
Product Benefits and Research Areas
- IGF-1 Signalling Research: Used in laboratory investigations of the insulin-like growth factor signalling pathway.
- Cell Growth Studies: Studied in experimental models involving cell proliferation and differentiation.
- Protein Metabolism Research: Relevant to research into pathways involved in protein synthesis and cellular metabolism.
- IGF-Binding Protein Interaction: Investigated because its structural modifications alter its interaction with IGF-binding proteins.
- Cellular Signalling: Used in research examining downstream pathways associated with growth-factor activity.
Important Safety Information
IGF-1 LR3 is an experimental peptide and is not an established or approved treatment for bodybuilding, muscle growth, or athletic performance. Its safety and effectiveness for these purposes have not been established. IGF-related compounds may affect blood glucose regulation and cell-growth pathways, and experimental exposure can carry significant risks. This product should not be presented as suitable for self-administration or human use.
Product Details: 200 mcg per vial, supplied as a pack of 5 vials.
Reviews
There are no reviews yet.